Harbinger Health

We are pleased to announce that our CEO, Steve Hahn, will join an Endpoints News hosted oncology discussion panel with other industry leaders on January 14th during the JPM Healthcare Conference. Learn more here: https://hrbn.gr/4fuLbiy

Cancer is a complicated disease. Different types cause different symptoms. That's why we're developing a smarter approach to detection that starts with blood-based tests that enable the detection of early cancer.

We are pioneering early cancer detection using biology insights and AI. Using biology guided machine learning approaches, we can accurately predict where and how cancer will grow and provide clues to help inform when and where to treat it. Learn more about us here: https://hrbn.gr/3P70CTm

At Harbinger Health, our goal is to fundamentally transform cancer care and create a future where we can detect cancer at its earliest stages. We believe in a world where early detection of cancer is not only possible but affordable and available, where we can identify those with cancer before they are called patients. https://hrbn.gr/4gJhZFB

At Harbinger Health, we intend to lead in shaping a future where we can identify cancer before it is visible or symptomatic by using our AI and proprietary biology insights. How? By creating a proactive paradigm which helps people live cancer-free for longer, adding years to life and life to years. https://hrbn.gr/4iHZROl

Our team had an amazing time at Tuesday's holiday cookie decorating event! It was such a joy to celebrate the holiday season together with this fantastic group! 🍪✨

The National Cancer Institute states that by 2040, the number of new cancer cases per year is expected to rise to 29.9 million and the number of cancer-related deaths to 15.3 million. We are bringing together unique insights into the biology of cancer’s origin with artificial intelligence and genetic screening technologies to meet the challenge of finding cancer at its inception. https://hrbn.gr/3B6o2Fl

"These product innovations complement the tremendous advances of our data science team. Holistically, with every step forward we take, we are getting closer towards our ultimate goal of creating tests that can integrate seamlessly into current and future care paradigms." - Tony Shuber, our Chief Innovation Officer. Read one of our newest press releases here: https://hrbn.gr/3ZHjRJx

We have discovered biological programs rooted in developmental biology that drive the earliest cellular changes in cancer and are common across most cancer types. We aim to see cancer at the beginning, even before it takes hold. https://hrbn.gr/3ZCw5Tz

Join our very own RuQuan and Steve as they sit down with Ysabel Duron from the Latino Cancer Institute for an engaging discussion on the deep-seated challenges and ongoing barriers to equitable cancer care in America, particularly with the Latino community. Tune in to explore how community-driven insights lead the way, lessons we’ve gained from the pandemic, and the path to making advancements in knowledge, medical care, and technology. https://hrbn.gr/3D6Ke2M